FIELD: chemistry.
SUBSTANCE: group of inventions relates to the chemical-pharmaceutical industry and is a process for the preparation of a pharmaceutical composition and the pharmaceutical composition itself for the treatment of inflammatory and / or obstructive airways diseases selected from the group consisting of bronchial asthma and obstructive bronchitis, characterized in that it is an inhalation solution comprising 1',3'-dinitroglycerol ester of 11(S),15(S)-dihydroxy-9-keto-5Z,13E-prostodienoic acid, polysorbate 80, benzalkonium chloride in a ratio of 1:2:1 and a pharmaceutically acceptable solvent that is an isotonic sodium chloride solution.
EFFECT: present composition has a physico-chemical stability, is resistant to microbial contamination and includes a minimum amount of auxiliary ingredients.
7 cl, 6 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
PROSTAGLANDIN-BASED BRONCHOLYTIC DRUG | 2012 |
|
RU2500397C1 |
AGENT FOR TREATING CHRONIC OBLITERATING PERIPHERAL VASCULAR DISEASES BASED ON PROSTAGLANDIN | 2018 |
|
RU2695068C1 |
AEROSOL FOR INHALATIONS IN OBSTRUCTIVE BRONCHITIS | 2020 |
|
RU2735502C1 |
COMBINATION OF R,R-GLYCOPYRROLATE AND MONTELUKAST FOR TREATMENT OF RESPIRATORY DISEASES AND BASED ON IT PHARMACEUTICAL COMPOSITION | 2006 |
|
RU2420285C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORINE | 2006 |
|
RU2421209C2 |
PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2642624C2 |
PHARMACEUTICAL COMPOSITIONS | 2011 |
|
RU2568882C2 |
PHARMACEUTICAL COMPOSITION CONTAINING ARFORMOTEROL AND FLUTICASONE FUROATE | 2013 |
|
RU2678992C2 |
STABLE SOLUTION OF FENOTEROL HYDROBROMIDE | 2012 |
|
RU2479304C1 |
AXELASTIN AND STEROIDS COMBINATION | 2003 |
|
RU2361593C2 |
Authors
Dates
2018-07-23—Published
2017-10-16—Filed